Streetbeat News

Analyst Ratings

TXG

Guggenheim analyst Subbu Nambi has downgraded 10x Genomics (NASDAQ:TXG) from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:01 pm

HUBG

In the past three months, 7 analysts have provided ratings for Hub Group (NASDAQ:HUBG), ranging from bullish to bearish. The average 12-month price target is $45.29, with a high of $49.00 and a low of $42.00. Recent ratings show a mix of 'Maintain' and 'Lower' actions, reflecting varied sentiments about the company's performance.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 12:01 pm

ALKT

Over the past three months, four analysts have shared their evaluations of Alkami Technology (NASDAQ:ALKT), revealing a range of outlooks from bullish to bearish. The average 12-month price target has risen by 1.89% to $31.25. Analysts have maintained or raised their ratings, reflecting a positive shift in sentiment.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 12:00 pm

MCK

B of A Securities analyst Michael Cherny maintains a Buy rating on McKesson (NYSE:MCK) and raises the price target from $590 to $670.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 12:00 pm

STWD

In the past three months, 4 analysts have provided ratings for Starwood Property Trust (NYSE: STWD), ranging from bullish to bearish. The average 12-month price target is $21.62, down 3.4% from the previous $22.38. Analysts from Raymond James, BTIG, Keefe, Bruyette & Woods, and JP Morgan have all lowered their price targets recently. Despite this, Starwood Property Trust has shown strong financial performance with significant revenue growth, high net margins, and efficient debt management.

Portfolio Pulse from Benzinga Insights

June 25, 2024 | 12:00 pm

RIVN

Guggenheim has initiated coverage on Rivian Automotive (NASDAQ:RIVN) with a Buy rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:58 am

NNE

Benchmark analyst Michael Legg maintains a Buy rating on Nano Nuclear Energy (NASDAQ:NNE) and raises the price target from $15 to $39.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:49 am

POOL

Baird analyst David Manthey maintains a Neutral rating on Pool Corporation (NASDAQ: POOL) but lowers the price target from $380 to $305.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:47 am

CLSD

Clearside Biomedical shares are trading higher after Oppenheimer initiated coverage with an Outperform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:47 am

GOSS

Gossamer Bio shares are trading higher after Oppenheimer initiated coverage with an Outperform rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 11:46 am